Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

May-June 2004; Volume 24,Issue 3B

Clinical Studies

  • You have access
    Presence of Human Papillomavirus in Tonsillar Cancer Is a Favourable Prognostic Factor for Clinical Outcome
    HANNA DAHLSTRAND (MELLIN), LISELOTTE DAHLGREN, DAVID LINDQUIST, EVA MUNCK-WIKLAND and TINA DALIANIS
    Anticancer Research May 2004, 24 (3B) 1829-1835;
  • You have access
    Combined Treatment with Histamine Dihydrochloride, Interleukin-2 and Interferon-α in Patients with Metastatic Melanoma
    PER LINDNÉR, MAGNUS RIZELL, JAN MATTSSON, KRISTOFFER HELLSTRAND and PETER NAREDI
    Anticancer Research May 2004, 24 (3B) 1837-1842;
  • You have access
    Phase I Study of Combination Therapy with S-1 and Docetaxel (TXT) for Advanced or Recurrent Gastric Cancer
    KAZUHIRO YOSHIDA, NAOKI HIRABAYASHI, WATARU TAKIYAMA, MOTOKI NINOMIYA, NORIHISA TAKAKURA, JYUNNICHI SAKAMOTO, MASAHIKO NISHIYAMA and TETSUYA TOGE
    Anticancer Research May 2004, 24 (3B) 1843-1851;
  • You have access
    Neoangiogenesis in Patients with Gastric Carcinoma in Relation to the Expression of Vascular Endothelial Growth Factor and Thymidine Phosphorylase
    SHUNICHI TSUJITANI, HIROAKI SAITO, YOSHIHIKO MAETA, KENICHI YAMAGUCHI, SHIGERU TATEBE, AKIRA KONDO and NOBUAKI KAIBARA
    Anticancer Research May 2004, 24 (3B) 1853-1859;
  • You have access
    Autologous Natural Killer Cell Therapy for Human Recurrent Malignant Glioma
    EIICHI ISHIKAWA, KOJI TSUBOI, KAORU SAIJO, HIDEKI HARADA, SHINGO TAKANO, TADAO NOSE and TADAO OHNO
    Anticancer Research May 2004, 24 (3B) 1861-1871;
  • You have access
    Gefitinib as Salvage Therapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer. Data from a Compassionate Use Program
    CESARE GRIDELLI, ANTONIO ROSSI, PAOLO MAIONE, CIRO GUERRIERO, GIUSEPPE AIROMA, GIUSEPPE COLANTUONI and MARIA LUISA BARZELLONI
    Anticancer Research May 2004, 24 (3B) 1873-1877;
  • You have access
    A Randomized Consent Design Trial of Neoadjuvant Chemotherapy with Tegafur Plus Uracil (UFT) for Gastric Cancer - A Single Institute Study
    YOSHINORI NIO, MAKOTO KOIKE, HIROSHI OMORI, KOJI HASHIMOTO, MASAYUKI ITAKURA, SEIJI YANO, TETSUYA HIGAMI and RIRUKE MARUYAMA
    Anticancer Research May 2004, 24 (3B) 1879-1887;
  • You have access
    Acetabular Osteosarcoma Treated by Irradiation-vascularized Hybrid Bone Graft
    TADAHIKO KUBO, TAKASHI SUGITA, SHOJI SHIMOSE, HARUYUKI TANAKA, HIROO NOBUTO, KUMI TANAKA and MITSUO OCHI
    Anticancer Research May 2004, 24 (3B) 1889-1892;
  • You have access
    Histological Findings in a Human Autogenous Pasteurized Bone Graft
    TADAHIKO KUBO, TAKASHI SUGITA, SHOJI SHIMOSE, KOJI ARIHIRO, HARUYUKI TANAKA, HIROO NOBUTO, KUMI TANAKA and MITSUO OCHI
    Anticancer Research May 2004, 24 (3B) 1893-1896;
  • You have access
    Kaposi's Sarcoma of the Tongue Associated with Median Rhomboid Glossitis in a Non-AIDS Patient. A Case Report
    R. ROSSIELLO, G. COLELLA, R.A. SATRIANO, A. VOZZA and L. ROSSIELLO
    Anticancer Research May 2004, 24 (3B) 1897-1900;
  • You have access
    Long-term Survival over 28 Years of a Patient with Metastatic Adrenal Cortical Carcinoma - Case Report
    ANDREAS MEYER and MATTHIAS BEHREND
    Anticancer Research May 2004, 24 (3B) 1901-1904;
  • You have access
    Primary Choriocarcinoma of the Lung
    YOSHIKI UMEMORI, AKIO HIRAKI, KEISUKE AOE, TOMOYUKI MURAKAMI, TADASHI MAEDA, EISUKE MATSUDA and HIROYASU TAKEYAMA
    Anticancer Research May 2004, 24 (3B) 1905-1910;
  • You have access
    Validation of the Limited-sampling Models for Carboplatin AUC in Combination Chemotherapy with Taxanes
    MITSURU MIYAZAKI, TETSUYA OGURI, TAKAYASU KURATA, TOSHIAKI TAKAHASHI, HARUKO DAGA, KAZUNORI FUJITAKA, TAKESHI ISOBE, MASAMITSU NAKAJIMA, YASUHIRO FUJIWARA and NOBUOKI KOHNO
    Anticancer Research May 2004, 24 (3B) 1911-1914;
  • You have access
    A Retrospective Study Focusing on Clinical Predictive Factors in 126 Patients with Oesophageal Carcinoma
    MARTIN DREILICH, STEFAN BERGSTRÖM, GUNNAR WAGENIUS, DANIEL BRATTSTRÖM and MICHAEL BERGQVIST
    Anticancer Research May 2004, 24 (3B) 1915-1920;
  • You have access
    Significance of T Stadium and Grading as Prognostic Factors in Transitional Cell Carcinoma of the Ureter
    ENRICO FIORI, GIUSEPPE CAVALLARO, CLAUDIA PAPARELLI, ALESSANDRO DECESARE, MARCO BONONI, GASPARE GALATI, GIUSEPPE TIZIANO, ANTONINO CAVALLARO and VINCENZO CANGEMI
    Anticancer Research May 2004, 24 (3B) 1921-1924;
  • You have access
    Bcl-2 Protein Expression Correlates with Better Prognosis in Patients with Advanced Non-small Cell Lung Cancer
    YOSHIHITO SHIBATA, SHIGEKAZU HIDAKA, YUTAKA TAGAWA and TAKESHI NAGAYASU
    Anticancer Research May 2004, 24 (3B) 1925-1928;
  • You have access
    Preoperative Chemolipiodolization of the Whole Liver for Hepatocellular Carcinoma
    MASAKI KAIBORI, NOBORU TANIGAWA, YOICHI MATSUI, A-HON KWON, SATOSHI SAWADA and YASUO KAMIYAMA
    Anticancer Research May 2004, 24 (3B) 1929-1933;
  • You have access
    Oxaliplatin Fractionated Over Two Days with Bimonthly Leucovorin and 5-Fluorouracil in Metastatic Colorectal Cancer
    FRANCESCO RECCHIA, SILVIO REA, ANTONIO NUZZO, ANGELO LALLI, LIBERATO DI LULLO, SANDRO DE FILIPPIS, GAETANO SAGGIO, EDOARDO BIONDI, ELENA MASSA and GIOVANNI MANTOVANI
    Anticancer Research May 2004, 24 (3B) 1935-1940;
  • You have access
    The Prognostic Value of Both Neuron-specific Enolase (NSE) and Cyfra21-1 in Small Cell Lung Cancer
    SOICHIRO ANDO, MAKOTO SUZUKI, NAOYOSHI YAMAMOTO, TOMOHIKO IIDA and HIDEKI KIMURA
    Anticancer Research May 2004, 24 (3B) 1941-1946;
  • You have access
    Tolerability of Adjuvant High-dose Interferon Alfa-2b: 1 Month Versus 1 Year-A Hellenic Cooperative Oncology Group Study
    HELEN GOGAS, DIMITRIOS BAFALOUKOS, JOHN IOANNOVICH, DIMOSTHENIS SKARLOS, ARIS POLYZOS, GEORGE FOUNTZILAS, HARALAMBOS P. KALOFONOS, GERASSIMOS ARAVANTINOS, DIMOSTHENIS TSOUTSOS, PETROS PANAGIOTOU, KONSTANTINA FRANGIA, THEODORA PETRAKOPOULOU and DIMITRIOS PECTASIDES
    Anticancer Research May 2004, 24 (3B) 1947-1952;
  • You have access
    CYFRA 21-1 and CEA are Independent Prognostic Factors in 153 Operated Stage I NSCLC Patients
    THOMAS MULEY, HENDRIK DIENEMANN and WERNER EBERT
    Anticancer Research May 2004, 24 (3B) 1953-1956;
  • You have access
    Epoetin Beta (NeoRecormon®) Corrects Anaemia in Patients with Hormone-refractory Prostate Cancer and Bone Metastases
    J. BOGDANOS, D. KARAMANOLAKIS, K. MILATHIANAKIS, P. REPOUSIS, A. CHLORAKI-BOBOTA, H. MAJED, E. PAGALOU-THOUA, A. TSINTAVIS and M. KOUTSILIERIS
    Anticancer Research May 2004, 24 (3B) 1957-1961;
  • You have access
    Epirubicin Plus Docetaxel in Metastatic Breast Cancer: Escalating Dose does not Improve Efficacy. A Phase II Study
    ALESSANDRA FABI, PAOLA PAPALDO, MARIA SIMONA PINO, GIANLUIGI FERRETTI, PAOLO CARLINI, UMBERTO PACETTI, SERENA DI COSIMO, CHIARA NARDONI, DIANA GIANNARELLI, ITALO SACCHI and FRANCESCO COGNETTI
    Anticancer Research May 2004, 24 (3B) 1963-1967;
  • You have access
    5FU and Oxaliplatin-containing Chemotherapy in Two Dihydropyrimidine Dehydrogenase-deficient Patients
    O. REERINK, N.H. MULDER, B.G. SZABO and G.A.P. HOSPERS
    Anticancer Research May 2004, 24 (3B) 1969-1971;
  • You have access
    Correlation of Serum VEGF Levels with Clinical Stage, Therapy Efficacy, Tumor Metastasis and Patient Survival in Ovarian Cancer
    LI LI, LIMEI WANG, WEI ZHANG, BUJIAN TANG, JIEQING ZHANG, HONGLIN SONG, DESHENG YAO, YONG TANG, XINQIU CHEN, ZHIHUA YANG, GANGDUO WANG, XIPING LI, JINSHUN ZHAO, HONG DING, EDDIE REED and QINGDI Q. LI
    Anticancer Research May 2004, 24 (3B) 1973-1979;
  • You have access
    The Prognostic Value of Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Stage III Ovarian Cancer Patients
    FARAH DIBA BEGUM, CLAUS K. HØGDALL, SUSANNE K. KJAER, LISE CHRISTENSEN, JAN BLAAKAER, JOHANNES E. BOCK, EVA GLUD, GUNILLA HØYER-HANSEN, HELMER RING-LARSEN and ESTRID V.S. HØGDALL
    Anticancer Research May 2004, 24 (3B) 1981-1985;
  • You have access
    Prognostic Significance of Serum HER2 and CA 15-3 at the Time of Diagnosis of Metastatic Breast Cancer
    TANJA FEHM, WOLFRAM JÄGER, STEFAN KRÄMER, CHRISTOF SOHN, ERICH SOLOMAYER, DIETHELM WALLWIENER and GERHARD GEBAUER
    Anticancer Research May 2004, 24 (3B) 1987-1992;
  • You have access
    Peroxisome Proliferator Activated Receptor Gamma Immunohistochemical Expression in Human Papillary Thyroid Carcinoma Tissues. Possible Relationship to Lymph Node Metastasis
    BOGDAN GALUSCA, JEAN MARC DUMOLLARD, MARIE LAURE CHAMBONNIERE, NATACHA GERMAIN, JEAN MICHEL PRADES, MICHEL PÉOC'H and BRUNO ESTOUR
    Anticancer Research May 2004, 24 (3B) 1993-1997;
  • You have access
    99m-Tc-MDP-Scintimammography in the Evaluation of Breast Masses or Tumor Angiogenesis
    NAZIM S. TURHAL, FAYSAL DANE, FUAT DEDE, MAHMUT GUMUS, P. FULDEN YUMUK, FULYA CAKALAGAOGLU, DILARA SAVCI, MUNIRE KARAMAN, BAHADIR GULLUOGLU and H.TURGUT TUROGLU
    Anticancer Research May 2004, 24 (3B) 1999-2006;
  • You have access
    Expression of Betacellulin, Heparin-binding Epidermal Growth Factor and Epiregulin in Human Malignant Fibrous Histiocytoma
    TETSUJI YAMAMOTO, TOSHIHIRO AKISUE, TAKASHI MARUI, TETSUYA NAKATANI, TERUYA KAWAMOTO, TOSHIAKI HITORA, KEIKO NAGIRA, IKUO FUJITA, KEIJI MATSUMOTO and MASAHIRO KUROSAKA
    Anticancer Research May 2004, 24 (3B) 2007-2010;
  • You have access
    Decrease in Specific Micronutrient Intake in Colorectal Cancer Patients with Tumors Presenting Ki-ras Mutation
    NURIA LASO, SERGI MAS, M. JOSE LAFUENTE, XAVIER CASTERAD, MANUEL TRIAS, ANTONIO BALLESTA, RAFAEL MOLINA, JORDI SALAS, CARLOS ASCASO, SHICHUN ZHENG, JOHN K. WIENCKE and AMALIA LAFUENTE
    Anticancer Research May 2004, 24 (3B) 2011-2020;
  • You have access
    Single Nucleotide Polymorphisms in MMP1 and MMP3 Gene Promoters as Risk Factor in Head and Neck Squamous Cell Carcinoma
    FRANCK ZINZINDOHOUÉ, HÉLENE BLONS, STÉPHANE HANS, MARIE-ANNE LORIOT, ANNE-MARIE HOULLIER, DANIEL BRASNU, OLLIVIER LACCOURREYE, DAVID-ALEXANDRE TREGOUET, ISABELLE STUCKER and PIERRE LAURENT-PUIG
    Anticancer Research May 2004, 24 (3B) 2021-2026;
  • You have access
    Circulating Soluble E-Cadherin Levels are of Prognostic Significance in Patients with Multiple Myeloma
    K.N. SYRIGOS, K. J. HARRINGTON, A.J. KARAYIANNAKIS, N. BAIBAS, N. KATIRTZOGLOU and P. ROUSSOU
    Anticancer Research May 2004, 24 (3B) 2027-2031;
  • You have access
    Possible Mechanism Pertinent to Mucosal Invasion in Sporadic Colonic Adenomas
    C.A. RUBIO
    Anticancer Research May 2004, 24 (3B) 2033-2036;
  • You have access
    Efficacy of Infusional Biomodulated 5-Fluorouracil in Metastatic Colorectal Cancer after Raltitrexed Failure
    LORE DECOSTER, BART NEYNS, HASENA AKOUAOUACH, CHRISTEL FONTAINE, DENIS SCHALLIER and JACQUES L.P. DE GRÈVE
    Anticancer Research May 2004, 24 (3B) 2037-2040;
  • You have access
    Pharmacokinetics of Cisplatin in Semi-closed Hyperthermic Peritoneal Perfusion (HPP) for Treatment of Peritoneal Carcinomatosis
    LUIGI CATTEL, MICHELE DE SIMONE, ROBERTO PASSERA, MARIA CRISTINA VERLENGO and LAURA DELPRINO
    Anticancer Research May 2004, 24 (3B) 2041-2045;
  • You have access
    Alterations of the K-ras and p53 Genes and Microsatellite Instability in Sporadic Colorectal Carcinomas
    ARIFUMI HASEGAWA, TOSHIHIKO FUKUSHIMA, MIYUKI MASHIKO, KEIICHI NAKANO, SATOSHI SUZUKI, YOSHIYUKI ENDO, SHINJI OHKI, YUICHI HATAKEYAMA, YOSHIHISA KOYAMA, NORIO INOUE, YUJI TAKEBAYASHI, KOUJI SEKIKAWA and SEI-ICHI TAKENOSHITA
    Anticancer Research May 2004, 24 (3B) 2047-2052;
  • You have access
    Thrombocytosis in Gynecologic Malignancies
    F. GÜCER, K. TAMUSSINO, F. KEIL, P. BALKANLI-KAPLAN and M. A. YÜCE
    Anticancer Research May 2004, 24 (3B) 2053-2059;
  • You have access
    Tumor Histology and Stage but Not p53, Her2-neu or Cathepsin-D Expression are Independent Prognostic Factors in Breast Cancer Patients
    D. P. KORKOLIS, E. TSOLI, D. FOUSKAKIS, J. YIOTIS, G. J. KOULLIAS, D. GIANNOPOULOS, E. PAPALAMBROS, N. I. NIKITEAS, C. A. SPILIOPOULOU, E. PATSOURIS, P. ASIMACOPOULOS and V.G. GORGOULIS
    Anticancer Research May 2004, 24 (3B) 2061-2068;
  • You have access
    Demographic and Clinical Factors as Determinants of Serum Levels of Prostate Specific Antigen and its Derivatives
    MARION A. GRAY, BRETT DELAHUNT, JEFFERSON R. FOWLES, PHILIP WEINSTEIN, RUSSELL R. COOKE and JOHN N. NACEY
    Anticancer Research May 2004, 24 (3B) 2069-2072;
  • You have access
    Prognostic Value of Pelvic Lymphadenectomy in Surgical Treatment of Apparent Stage I Endometrial Cancer
    MARCELLO CECCARONI, LUCA SAVELLI, ALESSANDRO BOVICELLI, CARLO ALBONI, MICHELA CECCARINI, ANTONIO FARINA and LUCIANO BOVICELLI
    Anticancer Research May 2004, 24 (3B) 2073-2078;
  • You have access
    Cardiotoxicity in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum and Non-platinum Based Combinations as First-line Treatment
    FLORIS M. WACHTERS, WINETTE T.A. VAN DER GRAAF and HARRY J.M. GROEN
    Anticancer Research May 2004, 24 (3B) 2079-2083;
  • You have access
    Combination Chemotherapy with Docetaxel and Doxifluridine showed a Beneficial Outcome in Advanced or Recurrent Breast Cancer Patients with Longer Disease-free Interval
    REIKI NISHIMURA, TAKESHI TOMINAGA, SHOSHU MITSUYAMA, HIDEAKI AOYAMA, TARO ASAGA, SHINJI OHNO, NOBUO OKUYAMA, MORIHIKO KIMURA, HIROTAKA IWASE, KAZUHIRO KANDA, TOSHIHIRO KOGA, EIICHI SHIBA and TADASHI IKEDA
    Anticancer Research May 2004, 24 (3B) 2085-2091;
  • You have access
    Oxaliplatin Hepatic Arterial Infusion Chemotherapy for Hepatic Metastases from Colorectal Cancer: A Phase I-II Clinical Study
    GIAMMARIA FIORENTINI, SUSANNA ROSSI, PATRIZIA DENTICO, FRANCESCO MEUCCI, FRANCESCO BONECHI, PAOLO BERNARDESCHI, MAURIZIO CANTORE, STEFANO GUADAGNI and MICHELE DE SIMONE
    Anticancer Research May 2004, 24 (3B) 2093-2096;
  • You have access
    Ten-year Disease-free Survival of a Small Cell Lung Cancer Patient with Brain Metastasis Treated with Chemoradiotherapy
    YUZURU NIIBE, KATSUYUKI KARASAWA and KAZUSHIGE HAYAKAWA
    Anticancer Research May 2004, 24 (3B) 2097-2100;
  • You have access
    Prognostic Impact of Tissue Inhibitor of Matrix Metalloproteinase- 1 in Plasma of Patients with Colorectal Cancer
    NORIO YUKAWA, TAKAKI YOSHIKAWA, MAKOTO AKAIKE, YUKIO SUGIMASA, SHOJI TAKEMIYA, SHUNSUKE YANOMA, TOSHIO IMADA and YOSHIKAZU NOGUCHI
    Anticancer Research May 2004, 24 (3B) 2101-2105;
  • You have access
    Gemcitabine and Continuous Infusion of 5-Fluorouracil in Locally Advanced and Metastatic Pancreatic Cancer: A Phase I-II Study
    C. OLIANI, M. PADOVANI, P. MANNO, D. BARANA, M. FALCONI, C. BASSI, G. CAVALLINI, P. PEDERZOLI and G.L. CETTO
    Anticancer Research May 2004, 24 (3B) 2107-2112;
  • You have access
    Serrated Adenomas of the Cardia
    C.A. RUBIO and J. LAGERGREN
    Anticancer Research May 2004, 24 (3B) 2113-2116;
  • You have access
    Instruments for Quality of Life Assessment in Patients with Gastrointestinal Cancer
    A.G. PALLIS and I.A. MOUZAS
    Anticancer Research May 2004, 24 (3B) 2117-2121;
  • You have access
    CD3 ζ Expression of Regional Lymph Node and Peripheral Blood Lymphocytes in Gastric Cancer
    SUMIYA ISHIGAMI, SHOJI NATSUGOE, FUTOSHI MIYAZONO, KOKI TOKUDA, AKIHIRO NAKAJO, MASATAKA MATSUMOTO, HIROSHI OKUMURA, SABURO NAKASHIMA, SHUICHI HOKITA, IKURO MARUYAMA and TAKASHI AIKOU
    Anticancer Research May 2004, 24 (3B) 2123-2126;
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 24, Issue 3B
May-June 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Sign up for alerts
Entire Issue ($200)

Jump to

  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire